MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Search

Madrigal Pharmaceuticals Inc

Suletud

SektorTervishoid

309.99 -2.95

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

306.27

Max

320

Põhinäitajad

By Trading Economics

Sissetulek

-14M

-73M

Müük

34M

137M

Kasumimarginaal

-53.361

Töötajad

528

EBITDA

-14M

-70M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+33.78% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

6. aug 2025

Turustatistika

By TradingEconomics

Turukapital

-213M

7.1B

Eelmine avamishind

312.94

Eelmine sulgemishind

309.99

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Madrigal Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. juuli 2025, 23:41 UTC

Market Talk

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

15. juuli 2025, 23:40 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

15. juuli 2025, 23:05 UTC

Market Talk

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

15. juuli 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. juuli 2025, 21:36 UTC

Market Talk

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

15. juuli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

15. juuli 2025, 20:50 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

15. juuli 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15. juuli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

15. juuli 2025, 20:14 UTC

Omandamised, ülevõtmised, äriostud

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

15. juuli 2025, 20:07 UTC

Tulu

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

15. juuli 2025, 20:06 UTC

Market Talk

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

15. juuli 2025, 19:54 UTC

Market Talk

Global Equities Roundup: Market Talk

15. juuli 2025, 19:54 UTC

Market Talk

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

15. juuli 2025, 19:38 UTC

Market Talk

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

15. juuli 2025, 19:09 UTC

Market Talk

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

15. juuli 2025, 19:07 UTC

Market Talk

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

15. juuli 2025, 19:03 UTC

Market Talk

Gold Slips as Big Buyers Pull Back -- Market Talk

15. juuli 2025, 18:32 UTC

Omandamised, ülevõtmised, äriostud

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15. juuli 2025, 18:31 UTC

Omandamised, ülevõtmised, äriostud

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

15. juuli 2025, 18:13 UTC

Market Talk

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

15. juuli 2025, 17:40 UTC

Market Talk

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

15. juuli 2025, 17:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. juuli 2025, 17:25 UTC

Omandamised, ülevõtmised, äriostud

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

15. juuli 2025, 17:24 UTC

Market Talk

Dollar Gains Strength After Inflation Data -- Market Talk

15. juuli 2025, 16:49 UTC

Market Talk

Oil Futures Likely to Continue Sideways Trade -- Market Talk

15. juuli 2025, 16:20 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

15. juuli 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15. juuli 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

15. juuli 2025, 15:42 UTC

Market Talk

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Madrigal Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

33.78% tõus

12 kuu keskmine prognoos

Keskmine 427.91 USD  33.78%

Kõrge 540 USD

Madal 248 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Madrigal Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

13 ratings

11

Osta

1

Hoia

1

Müü

Tehniline skoor

By Trading Central

263.2 / 277.1Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Neutral Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.